Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Sunleca
Pharma
GSK bolsters case for long-acting HIV PrEP drug Apretude
With GSK girding for competition from Gilead, the company has presented strong results from three real-world studies of HIV prevention drug Apretude.
Kevin Dunleavy
Oct 16, 2024 1:26pm
Gilead inks licensing deals to boost lenacapivir access
Oct 2, 2024 3:14pm
Gilead races toward filings for long-acting PrEP after trial win
Sep 12, 2024 11:45am
Gilead’s twice-yearly PrEP drug shows 100% efficacy
Jun 20, 2024 11:45am
'The Top Line': 2022's rotten tomatoes, plus this week's news
Jan 6, 2023 6:00am
